Successful repeated laparoscopic liver resection for multiple colorectal metastasis in an elderly patient with multiple antiplatelets for high thromboembolic risks

Takahisa Fujikawa


We experienced a case of an elderly dual antiplatelet-burdened woman with high thromboembolic risks, undergoing repeated laparoscopic liver resection combined with multidrug chemotherapy for multiple bilobar liver metastases from colorectal cancer. Finally, R0 resection followed by the long-term survival was achieved. Combination of multidrug chemotherapy, repeated laparoscopic liver resection, and rigorous perioperative antithrombotic management with continuous aspirin monotherapy is one of the promising options for such high thromboembolic  cases.


laparoscopic liver resection, repeated liver resection, colorectal liver metastasis, antiplatelet therapy, arterial thromboembolic risk


Fujikawa T, Tanaka A, Abe T, et al. Does antiplatelet therapy affect outcomes of patients receiving abdominal laparoscopic surgery? Lessons from more than 1,000 laparoscopic operations in a single tertiary referral hospital. J Am Coll Surg. 2013;217(6):1044-1053. doi:S1072-7515(13)01019-3 [pii] 10.1016/j.jamcollsurg.2013.08.005

Fujikawa T, Tanaka A, Abe T, Yoshimoto Y, Tada S, Maekawa H. Effect of antiplatelet therapy on patients undergoing gastroenterological surgery: thromboembolic risks versus bleeding risks during its perioperative withdrawal. World J Surg. 2015;39(1):139-149. doi:10.1007/s00268-014-2760-3

Sugihara K, Uetake H. Therapeutic strategies for hepatic metastasis of colorectal cancer: overview. J Hepatobiliary Pancreat Sci. 2012;19(5):523-527. doi:10.1007/s00534-012-0524-8

Wang C-C, Li J. An update on chemotherapy of colorectal liver metastases. World J Gastroenterol. 2012;18(1):25-33. doi:10.3748/wjg.v18.i1.25

Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240(4):644-57; discussion 657-8. doi:10.1097/01.sla.0000141198.92114.f6

Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208-1215. doi:10.1016/S1470-2045(13)70447-9

Nguyen KT, Laurent A, Dagher I, et al. Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Ann Surg. 2009;250(5):842-848. doi:10.1097/SLA.0b013e3181bc789c

Full Text: PDF HTML


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.